Elutia Inc. (ELUT) Financial Ratios
8 years of historical data (2018–2025) · Healthcare · Biotechnology
EV/EBITDA
N/A
—
5yr avg: N/A
P/FCF
N/A
—
5yr avg: N/A
P/B Ratio
↓
1.66
↓-45% vs avg
5yr avg: 3.01
30Y Low1.2·High6.7
ROE
↑
192.9%
↓+180% vs avg
5yr avg: -242.3%
30Y Low-145%·High193%
Debt/EBITDA
N/A
—
5yr avg: N/A
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
ELUT Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Elutia Inc. trades at 0.8x earnings, 44% above its 5-year average of 0.5x, sitting at the 100th percentile of its historical range. Compared to the Healthcare sector median P/E of 22.3x, the stock trades at a discount of 97%.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $45M | $32M | $109M | $39M | $59M | $66M | $139M | — | — |
| Enterprise Value | $17M | $3M | $120M | $44M | $67M | $59M | $131M | — | — |
| P/E Ratio → | 0.77 | 0.54 | — | — | — | — | — | — | — |
| P/S Ratio | 3.70 | 2.59 | 4.46 | 1.59 | 2.47 | 1.39 | 3.27 | — | — |
| P/B Ratio | 1.66 | 1.15 | — | — | — | 4.87 | 6.69 | — | — |
| P/FCF | — | — | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
ELUT EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.25 | 4.93 | 1.77 | 2.82 | 1.24 | 3.07 | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — | — |
ELUT Profitability
Margins and return-on-capital ratios measuring operating efficiency
Elutia Inc. earns an operating margin of -149.8%. Operating margins have compressed from -123.4% to -149.8% over the past 3 years, signaling potential cost pressures or competitive headwinds. Return on equity of 192.9% is exceptionally high, though this is partly amplified by negative book value driven by aggressive share buybacks.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 53.7% | 53.7% | 43.9% | 44.7% | 48.8% | 40.1% | 48.2% | 46.1% | 40.8% |
| Operating Margin | -149.8% | -149.8% | -146.3% | -123.4% | -147.5% | -48.6% | -31.9% | -19.6% | -21.1% |
| Net Profit Margin | 434.2% | 434.2% | -221.3% | -152.2% | -137.9% | -52.4% | -51.1% | -27.8% | -29.6% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| ROE | 192.9% | 192.9% | — | — | -775.1% | -144.6% | -104.8% | — | — |
| ROA | 108.4% | 108.4% | -135.6% | -67.1% | -48.4% | -33.1% | -34.2% | -25.8% | -24.2% |
| ROIC | — | — | — | — | -539.1% | -184.9% | -82.8% | -280.1% | -16.9% |
| ROCE | -103.6% | -103.6% | — | -229.4% | -104.4% | -47.4% | -33.0% | -27.6% | -23.9% |
ELUT Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
The company holds a net cash position — cash of $36M exceeds total debt of $8M, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.27 | 0.27 | — | — | — | 1.72 | 1.47 | — | — |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — |
| Net Debt / Equity | — | -1.04 | — | — | — | -0.53 | -0.41 | — | — |
| Net Debt / EBITDA | — | — | — | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | — | — | — | — |
| Interest Coverage | — | — | -7.46 | -5.27 | -6.88 | -4.33 | -2.41 | -1.56 | -1.49 |
Net cash position: cash ($36M) exceeds total debt ($8M)
ELUT Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
Elutia Inc.'s current ratio of 2.22x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The current ratio has improved from 0.73x to 2.22x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.22 | 2.22 | 0.69 | 0.73 | 1.19 | 1.82 | 2.23 | 1.01 | 1.36 |
| Quick Ratio | 2.12 | 2.12 | 0.59 | 0.64 | 1.09 | 1.46 | 1.85 | 0.62 | 0.80 |
| Cash Ratio | 1.45 | 1.45 | 0.35 | 0.45 | 0.40 | 1.17 | 1.46 | 0.14 | 0.18 |
| Asset Turnover | — | 0.20 | 0.67 | 0.57 | 0.35 | 0.71 | 0.52 | 0.96 | 0.82 |
| Inventory Turnover | 2.18 | 2.18 | 3.49 | 3.55 | 2.88 | 2.97 | 2.19 | 3.22 | 3.10 |
| Days Sales Outstanding | — | 195.37 | 105.36 | 87.90 | 269.16 | 46.18 | 61.28 | 61.50 | 67.32 |
ELUT Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Elutia Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business. The earnings yield of 100.0% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 100.0% | 186.1% | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 1.1% | 0.1% | 0.0% | 0.0% | 0.0% | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 1.1% | 0.1% | 0.0% | 0.0% | 0.0% | — | — |
| Shares Outstanding | — | $46M | $29M | $18M | $14M | $10M | $10M | $11M | $11M |
Peer Comparison
Compare ELUT with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 ELUTYou | $45M | 0.8 | — | — | 53.7% | -149.8% | 192.9% | — | — |
 NVCR | $2B | -13.8 | — | — | 74.5% | -23.5% | -38.9% | -16.4% | — |
 XTNT | $80M | -4.8 | — | — | 58.2% | -10.3% | -34.9% | -12.8% | — |
 OSBC | $1B | 13.0 | 11.0 | 9.4 | 78.1% | 27.9% | 10.2% | 8.1% | 2.8 |
 LMAT | $2B | 42.8 | 33.4 | 33.0 | 71.5% | 27.2% | 15.8% | 9.7% | 2.4 |
 MDT | $100B | 21.6 | 14.3 | 19.3 | 65.3% | 17.8% | 9.4% | 6.0% | 3.2 |
 ABT | $151B | 11.4 | 15.8 | 23.8 | 50.8% | 16.3% | 30.9% | 9.9% | 1.5 |
 BSX | $84B | 29.2 | 25.3 | 23.0 | 69.0% | 19.8% | 12.4% | 8.8% | 3.3 |
 SYK | $113B | 35.0 | 20.3 | 26.3 | 64.0% | 19.5% | 15.1% | 11.4% | 2.4 |
 ZBH | $16B | 23.5 | 9.5 | 11.1 | 61.6% | 16.5% | 5.6% | 5.4% | 3.1 |
 GMED | $12B | 21.7 | 18.5 | 19.5 | 67.4% | 16.3% | 12.3% | 8.9% | 0.2 |
| Healthcare Median | — | 22.3 | 14.5 | 18.5 | 64.0% | -5.2% | -33.7% | -11.2% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 8 years · Updated daily
See ELUT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ELUT Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ELUT vs NVCR
Side-by-side business, growth, and profitability comparison vs NovoCure Limited.
Start ComparisonELUT — Frequently Asked Questions
Quick answers to the most common questions about buying ELUT stock.
What is Elutia Inc.'s P/E ratio?
Elutia Inc.'s current P/E ratio is 0.8x. The historical average is 0.5x. This places it at the 100th percentile of its historical range.
What is Elutia Inc.'s ROE?
Elutia Inc.'s return on equity (ROE) is 192.9%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is -18.8%.
Is ELUT stock overvalued?
Based on historical data, Elutia Inc. is trading at a P/E of 0.8x. This is at the 100th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What are Elutia Inc.'s profit margins?
Elutia Inc. has 53.7% gross margin and -149.8% operating margin.